Peter Collins
Vermögen: 144 900 $ am 31.05.2026
Vermögen: 144 900 $ am 31.05.2026
Peter Michael Collins is the founder of European Personalised Medicine Association.
Mr. Collins is Chief Executive Officer & Director at CelLBxHealth Plc since 2026.
Mr. Collins was Chief Executive Officer at SAGA Diagnostics AB. Mr. Collins was Director & Chief Commercial Officer at Yourgene Health Ltd. Mr. Collins was Vice President & Head-Diagnostics at GSK Plc.
Mr. Collins was Principal at Riverside Biosciences Ltd., BioGenex Laboratories, Inc., Gentronix Ltd., and Pronostics Ltd. Mr. Collins was Senior Vice President-Pharma Business Development at DxS Ltd. Mr. Collins was Vice President-Marketing & Sales at Abbott Molecular Diagnostics.
Mr. Collins was Vice President-Pharma Business Development at QIAGEN Ltd.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CELLBXHEALTH PLC 0.44% | 18.12.2025 | 5’000’000 ( 0.44% ) | 144 900 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLBXHEALTH PLC | Vorstandsvorsitzender | 16.10.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| YOURGENE HEALTH | Direktor/Vorstandsmitglied | 01.11.2018 |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Vorstandsvorsitzender | - |
| GSK PLC | Corporate Officer/Principal | - |
Qiagen Ltd.
Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities | Corporate Officer/Principal | - |
European Personalised Medicine Association | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 12 |
|---|---|
CelLBxHealth Plc
CelLBxHealth Plc Medical DistributorsDistribution Services Operates as a holding company with interests in providing products in cancer diagnostics and foetal health | Distribution Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Riverside Biosciences Ltd.
Riverside Biosciences Ltd. Medical SpecialtiesHealth Technology Produces neo natal blood testing kits | Health Technology |
BioGenex Laboratories, Inc.
BioGenex Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Provides solutions for automation of cell and tissue testing | Health Technology |
Gentronix Ltd.
Gentronix Ltd. BiotechnologyHealth Technology Provides services and solutions to help organizations optimize the development of drugs and other chemicals | Health Technology |
Pronostics Ltd.
Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Provides and develops diagnostic test for heart disease | Health Technology |
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Health Technology |
Abbott Molecular Diagnostics | |
Qiagen Ltd.
Qiagen Ltd. Medical/Nursing ServicesHealth Services Engages in other human health activities | Health Services |
European Personalised Medicine Association | |
Yourgene Health Plc
Yourgene Health Plc Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen